Facilitating global access to diabetes treatments for non-EU patients, CHMP, 22/04/2022

This PRESS RELEASE was originally published on THIS SITE

EMA’s human medicines committee (CHMP) has given a recommendation for two diabetes mellitus treatments, Actrapid and Insulatard, for use outside the…